Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sigma-RX Pharmaceuticals is a specialty pharmaceutical company based in Florham Park, New Jersey, focused on the development, manufacturing, and commercialization of generic drug products. The company specializes in creating high-quality, affordable versions of brand-name medications, particularly those involving complex formulations and oral solid dosage forms. Sigma-RX operates state-of-the-art facilities that adhere to current Good Manufacturing Practice (cGMP) standards to ensure the safety and efficacy of its products. Their business model centers on the submission of Abbreviated New Drug Applications (ANDAs) to the FDA, targeting niche markets and difficult-to-manufacture generics. By leveraging its internal R&D expertise, Sigma-RX aims to improve patient access to essential medicines while providing value to the broader healthcare system.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sigma RX.